The last newsletter of 2024 is out! As usual, check your spam box if you have not received it! Thank you to all the warriors that replied with Christmas wishes, they were greatly appreciated!
Happy and fruitful 2025, see you next year!
Max
Newsletter number 7: The last... - Fight Prostate Ca...
Newsletter number 7
Written by
Maxone73
To view profiles and participate in discussions please or .
5 Replies
•
Thank you and Happy New Year to you and everyone here!
How do you subscribe?
Not what you're looking for?
You may also like...
My newsletter
Hi!
I have noticed that some of you are sending newsletter subscriptions even if they have already...
5th Newsletter sent!
As usual, if you have subscribed, please check your spam folder in case you have not received it....
As usual, newsletter sent!
this time featuring more clinical than preclinical research updates. That’s not to say there aren’t...
Gleason 7
I have been told my condition is localised and my Gleason score is 7. I am meeting with the Nurse...
Gleason 7 Prostate cancer Problem
Hi all.as you can see from the above post I have recently been diagnosed with Prostate Cancer.I...
Related Posts
Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States
Pinostilbene inhibits the Enz-resistant CRPC cell line by inhibiting AR variant 7
HELP, Intraductal with Cribriform 4+3=7 treatment options 
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment - JAMA Oncology, Nov 7, 2024 - w/ SWOG commentary- Dual ARi in mCRPCa - Antonarakis = 'Combo of 2 AR-directed agents should not be utilized in clinical practice at this time', MedPage 7/20/23
